News

The internationally renowned cancer centre is working on the project – billed as the UK's first large-scale, AI-powered radiology platform for cancer research – with digital transformation specialist ...
The results show an impressive 63% objective response rate (ORR) in 43 evaluable patients in a phase 2 trial, as of a 27th ...
Beghou Consulting hires new CEO, AI expert. Beghou Consulting, an Evanston, Illinois-based consultancy firm supporting life ...
The field of 3D bioprinting technology is witnessing rapid advancements, offering new possibilities in regenerative medicine, tissue engineering, and pharmaceutical research. Some of the trends that ...
Sanofi has been given a reprimand by the UK's Prescription Medicines Code of Practice Authority (PMCPA), after admitting that ...
Autolus' CAR-T cell therapy for a rare and aggressive form of acute lymphoblastic leukaemia (ALL), Aucatzyl, has been ...
Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...
Artificial intelligence (AI) and other innovations in data science are making these advances possible – but at this point, ...
The most successful pharma sales teams will be those that define and service customers in new ways. Those who are the most responsive and relevant to today's customers and influencers will reap ...
Shares in PolyPid have been under pressure after the Israeli biotech reported its antibiotic for surgical site infections failed a phase 3 trial, although there may still be a way forward for the ...
The demise of the pharmaceutical sales representative has been greatly exaggerated over the years. But in the wake of the COVID-19 pandemic, there is an even greater need to re-examine the rep's role.
Using vaccine hesitancy as an example, the research on how to best get through to vaccine-hesitant parents or patients is still unsettled (see for example Dubé et al. 2014, Jarrett et al. 2015 ...